Showing results (161-170 of 494) with videos related to
Sort By:
Pageof 50
Drug Discovery Today. Technologies|September 21, 2013
Multicomponent reactions - opportunities for the pharmaceutical industryEelco Ruijter, Romano V A OrruDrug Discovery Today. Technologies|September 21, 2013
Metal-free bioconjugation reactionsSander S van Berkel, Floris L van DelftDrug Discovery Today. Technologies|September 21, 2013
Continuous flow synthesisJun-ichi Yoshida, Aiichiro Nagaki, Daisuke YamadaDrug Discovery Today. Technologies|September 21, 2013
In vivo strategies for drug discovery in myotonic dystrophy disordersIrma Garcia-Alcover, Arturo López Castel, Manuel Perez-Alonso, et al.Drug Discovery Today. Technologies|September 21, 2013
Alzheimer's disease drug discovery: in vivo screening using Caenorhabditis elegans as a model for β-amyloid peptide-induced toxicityA L Lublin, C D LinkDrug Discovery Today. Technologies|September 21, 2013
Drug metabolism in silico - the knowledge-based expert system approach. Historical perspectives and current strategiesAnthony LongDrug Discovery Today. Technologies|September 21, 2013
Modelling cytochromes P450 binding modes to predict P450 inhibition, metabolic stability and isoform selectivityEmanuele CarosatiDrug Discovery Today. Technologies|September 21, 2013
Inhibition of cytochrome P450 enzymes and biochemical aspects of mechanism-based inactivation (MBI)Amin Kamel, Shawn HarrimanDrug Discovery Today. Technologies|September 21, 2013
Chemogenomics of allosteric binding sites in GPCRsDavid E GloriamDrug Discovery Today. Technologies|January 2, 2021
The good, the bad, and the ugly in chemical and biological data for machine learningTiago RodriguesPageof 50